Brivanib in Combination With Notch3 Silencing Shows Potent Activity in Tumour Models

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-018-0375-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Corrigendum to ‘Targeting FGFR2 With Alofanib (RPT835) Shows Potent Activity in Tumour Models’ [Eur J Cancer 61 (2016) 20–28]

European Journal of Cancer
Cancer ResearchOncology
2017English

TAS0728, a Covalent-Binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Artesunate Shows Potent Anti-Tumor Activity in B-Cell Lymphoma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

Carboplatin and Oxaliplatin in Sequenced Combination With Bortezomib in Ovarian Tumour Models

Journal of Ovarian Research
GynecologyOncologyObstetrics
2013English

Non-Canonical NOTCH3 Signalling Limits Tumour Angiogenesis

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

TAS4464, a Highly Potent and Selective Inhibitor of NEDD8 Activating Enzyme, Suppresses Neddylation and Shows Antitumor Activity in Diverse Cancer Models

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

A Dinucleotide Motif in Oligonucleotides Shows Potent Immunomodulatory Activity and Overrides Species-Specific Recognition Observed With CpG Motif

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2003English

Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination With Vorinostat in KRAS-Mutant Colorectal Cancer Models

Clinical Cancer Research
Cancer ResearchOncology
2011English

NIM811, a Cyclophilin Inhibitor, Exhibits Potent in Vitro Activity Against Hepatitis C Virus Alone or in Combination With Alpha Interferon

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy